SLAMF7 CAR-T cells derived from the huLuc63 antibody (elotuzumab) have been shown to kill not only the bone marrow MM cells but also extramedullary MM cells in murine xenograft model [114]. This evidence concerns the gene SLAMF7 and Miyoshi myopathy.